We studied, by real-time PCR, the differences in NLRP3 gene expression profiles between three different groups: healthy subjects (control), ALS patients and patients with other myopathies (OMP) (Table 1). The gene discussed is NLRP3; the disease is amyotrophic lateral sclerosis.